Covered recipient · General Payments record
ROLLIE D ROSETE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$10,549.80
- Reported across 554 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $274.53 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $103.01 | 4 |
| Lilly USA, LLC | $42.84 | 2 |
| ABBVIE INC. | $40.13 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $37.41 | 2 |
| Amgen Inc. | $19.80 | 1 |
| GlaxoSmithKline, LLC. | $18.17 | 1 |
| Acerta Pharma LLC | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.43 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105977118 | CMS |
| ABBVIE INC. | $18.70 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105977120 | CMS |
| Amgen Inc. | $19.80 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117670161 | CMS |
| Astellas Pharma US Inc | $23.50 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139291062 | CMS |
| Astellas Pharma US Inc | $28.99 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139318494 | CMS |
| Astellas Pharma US Inc | $23.55 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139334206 | CMS |
| Astellas Pharma US Inc | $26.97 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139384038 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.17 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104420575 | CMS |
| GlaxoSmithKline, LLC. | $18.17 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116199377 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $16.80 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146754217 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $20.61 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146755477 | CMS |
| Lilly USA, LLC | $15.55 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135377080 | CMS |
| Lilly USA, LLC | $27.29 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135338537 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.